Supporting information for De Vivo et al. (2002) Proc. Natl. Acad. Sci. USA, 10.1073/pnas.192172299

 

Table 3. Population characteristics at diagnosis

 

Cases (n = 187)

Controls (n = 397)

P

 value

Age, mean (SD)

57.8 (8)

57.3 (7)

 

Hormone replacement therapy, n (%)

      Ever

75 (40)

137 (35)

 

      Never

54 (29)

172 (43)

 

      Premenopausal

54 (29)

83 (21)

 

      Uncertain or missing

4 (2)

5 (1)

 

Age at menarche in yr, mean (SD)

12.4 (1)

12.5 (1)

0.31

Body mass index, mean (SD) kg/m2

27.8 (7)

25.5 (5)

<0.0001

Weight gain since age 18, mean (SD)

16.6 (15)

10.9 (12)

<0.0001

Parity, mean (SD)

2.8 (2)

3.1 (2)

0.04

Age at first birth, mean (SD)

21.3 (9)

23.2 (8)

0.01

First degree family history, n (%)

      Endometrial cancer

17 (9)

18 (5)

0.03

      Colorectal cancer

42 (22)

59 (15)

0.02

      Breast cancer

33 (18)

57 (14)

0.30

      Ovarian cancer

7 (4)

12 (3)

0.65

Ethnicity/ancestry, n (%)

      Southern European

27 (15)

52 (14)

0.40

      Scandinavian

13 (7)

26 (7)

 

      Other Caucasian

102 (58)

251 (66)

 

      Other

35 (20)

51 (13)

 

Oral contraceptive use, n (%)

      Never

120 (64)

244 (62)

0.28

      Past

66 (35)

151 (38)

 

      Current

1 (1)

0 (0)

 

Pack-years, mean (SD)

12.3 (20)

18.3 (23)

0.001

Alcohol use, mean (SD)

4.4 (8)

5.7 (10)

0.09